Solanezumab

DB11756InvestigationalProtein Based Therapies

Solanezumab is under investigation for the treatment of Dementia, Alzheimers Disease, and Alzheimers Disease, Familial.

Mechanism
Curator reviewed
Also known as
LY2062430

Resolves to

Compound
UNII5D6PWO0333CAS955085-14-0
Targets
P05067APP

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
382Drug interactionsStructured to mechanism, not free text
Sign in
8Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Solanezumab, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In